Filovirus infection of STAT-1 knockout mice

Journal of Infectious Diseases

Volumn 204, Issue SUPPL. 3, 2011, Pages

  Raymond, Jolynne ^a   Bradfute, Steven ^b   Bray, Mike ^c  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^b UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; EBOLA VACCINE; GAMMA INTERFERON; STAT1 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; EBOLA HEMORRHAGIC FEVER; EBOLA VIRUS; FEMALE; GENE DELETION; INFECTION SENSITIVITY; LETHALITY; LIVER; LYMPHOID TISSUE; MALE; MARBURG HEMORRHAGIC FEVER; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESTON EBOLAVIRUS; STAT1 GENE; SUDAN EBOLAVIRUS; VACCINATION; VIRUS LIKE AGENT; VIRUS STRAIN; VIRUS VIRULENCE; WILD TYPE; ZAIRE EBOLAVIRUS;

ANIMALS; EBOLA VACCINES; EBOLAVIRUS; FEMALE; HEMORRHAGIC FEVER, EBOLA; IMMUNIZATION SCHEDULE; IMMUNOGLOBULIN M; MALE; MARBURG VIRUS DISEASE; MARBURGVIRUS; MICE; MICE, KNOCKOUT; STAT1 TRANSCRIPTION FACTOR; TIME FACTORS; VIRULENCE;

EID: 80054770819     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir335     Document Type: Article

References (14)

1. Bray M. The role of the type I interferon response in the resistance of mice to filovirus infection. J Gen Virol 2001; 82:1365-73. (Pubitemid 32519767)
2. Bray M, Davis K, Geisbert T, Schmaljohn C, Huggins J. A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever. J Infect Dis 1998; 178:651-61. (Pubitemid 28397211)
3. Durbin JE, Fernandez-Sesma A, Lee CK, et al. Type I IFN modulates innate and specific antiviral immunity. J Immunol 2000; 164:4220-8.
4. Warfield KL, Olinger G, Deal EM, et al. Induction of humoral and CD81 T cell responses are required for protection against lethal Ebola virus infection. J Immunol 2005; 175:1184-91. (Pubitemid 41095006)
5. Hevey M, Negley D, Geisbert J, Jahrling P, Schmaljohn A. Antigenicity and vaccine potential of Marburg virus glycoprotein expressed by baculovirus recombinants. Virology 1997; 239:206-16. (Pubitemid 28027084)
6. Gibb TR, BrayM, Geisbert TW, et al. Pathogenesis of experimental Ebola Zaire virus infection in BALB/c mice. J Comp Pathol 2001; 125:233-42. (Pubitemid 34023736)
7. Bente DA, Alimonti JB, Shieh WJ, et al. Pathogenesis and immune response of Crimean-Congo hemorrhagic fever virus in a STAT-1 knockout mouse model. J Virol 2010; 84:11089-100.
8. Dupuis S, Jouanguy E, Al-Hajjar S, et al. Impaired response to interferon- alpha/beta and lethal viral disease in human STAT1 deficiency. Nat Genet 2003; 33:388-91. (Pubitemid 36278855)
9. Chapgier A, Wynn RF, Jouanguy E, et al. Human complete Stat-1 deficiency is associated with defective type I and II IFN responses in vitro but immunity to some low virulence viruses in vivo. J Immunol 2006; 176: 5078-83.
10. Geisbert TW, Hensley LE, Gibb TR, Steele KE, Jaax NK, Jahrling PB. Apoptosis induced in vitro and in vivo during infection by Ebola and Marburg viruses. Lab Invest 2000; 80:171-86. (Pubitemid 30120970)
11. Baize S, Leroy EM, Georges-Courbot MC, et al. Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients. Nat Med 1999; 5: 423-6. (Pubitemid 29180581)
12. Parrino J, Hotchkiss R, Bray M. Prevention of immune cell apoptosis as a potential therapeutic strategy for severe infections. Emerg Infect Dis 2007; 13:191-8. (Pubitemid 46193160)
13. Bradfute SB, Warfield KL, Bavari S. Functional CD81 T cell responses in lethal Ebola virus infection. J Immunol 2008; 180: 4058-66.
14. Vancott JL, McNeal MM, Choi AH, Ward RL. The role of interferons in rotavirus infections and protection. J Interferon Cytokine Res 2003; 23:163-70. S990 d (Pubitemid 36408148)